| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $4.7M | — | -55.4% |
| SG&A Expense | $2.1M | — | -32.4% |
| Operating Income | -$6.8M | — | +50.1% |
| Income Tax | $18K | — | — |
| Net Income | -$5.7M | — | +53.1% |
| EPS (Basic) | -$0.06 | — | +57.1% |
| EPS (Diluted) | -$0.06 | — | +57.1% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $131.7M | +28.4% | +9.1% |
| Total Assets | $133.0M | +28.1% | +7.2% |
| Total Liabilities | $6.4M | -28.8% | -51.5% |
| Stockholders' Equity | $126.6M | +33.5% | +14.2% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$7.2M | — | +41.0% |
| Financing Cash Flow | $36.3M | — | +5030.4% |